PRF Technologies (PRFX) Change in Account Payables (2020 - 2024)
PRF Technologies' (PRFX) quarterly Change in Account Payables came in at -$761000.0 in Q2 2024, down 1327.42% YoY from $62000.0 in Q3 2023, and down 189.01% on a QoQ basis from $855000.0 in Q1 2024.
PRF Technologies (PRFX) Change in Account Payables (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has 5 years of Change in Account Payables data on file, last reported at -$761000.0 in Q2 2024.
- Quarterly Change in Account Payables fell 1327.42% year-over-year to -$761000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$30000.0 (down 105.41% YoY) and the FY2024 annual result came in at $91000.0, up 78.43% from the prior year.
- Change in Account Payables retreated to -$761000.0 in Q2 2024, from $855000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $855000.0 in Q1 2024 to a low of -$761000.0 in Q2 2024.
- A 5-year average of $60529.4 and a median of $62000.0 in 2023 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 656.64% in 2024, down 1327.42% in 2024.
- Tracing PRFX's Change in Account Payables over 5 years: stood at $172000.0 in 2020, then retreated by 1.16% to $170000.0 in 2021, then surged by 178.82% to $474000.0 in 2022, then sank by 84.39% to $74000.0 in 2023, then sank by 1128.38% to -$761000.0 in 2024.
- The last three Change in Account Payables figures came in at -$761000.0 (Q2 2024), $855000.0 (Q1 2024), and $74000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | PRF Technologies | 647,973.00 | -3.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -761,000.00 |
| Jun 30, 2024 | -761,000.00 |
| Mar 31, 2024 | 855,000.00 |
| Mar 31, 2024 | 855,000.00 |
| Dec 31, 2023 | 74,000.00 |
| Dec 31, 2023 | 74,000.00 |
| Sep 30, 2023 | -198,000.00 |
| Sep 30, 2023 | -198,000.00 |
| Jun 30, 2023 | 62,000.00 |
| Jun 30, 2023 | 62,000.00 |
| Mar 31, 2023 | 113,000.00 |
| Mar 31, 2023 | 113,000.00 |
| Sep 30, 2022 | 474,000.00 |
| Sep 30, 2022 | 474,000.00 |
| Jun 30, 2022 | -94,000.00 |
| Jun 30, 2022 | -94,000.00 |
| Mar 31, 2022 | -186,000.00 |
| Mar 31, 2022 | -186,000.00 |
| Dec 31, 2021 | 170,000.00 |
| Dec 31, 2021 | 170,000.00 |